Pfizer, Moderna lose bids to dismiss Bayer mRNA patent lawsuit
US judge in Delaware rejected the companies' requests to dismiss Bayer's Monsanto unit patent claims over mRNA technology used in COVID-19 vaccines.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Pfizer, Moderna lose bids to escape Bayer US mRNA patent lawsuit
By Blake BrittainA federal judge in Delaware on Monday rejected Pfizer NYSE:PFE, BioNTech NASDAQ:BNTX and Moderna's NASDAQ:MRNA requests to dismiss patent lawsuits filed against them by Bayer's XETR:BAYN Monsanto unit over the messenger RNA technology used in their COVID-19 vaccines.The cases are B…